{
  "paper_metadata": {
    "pmid": "34550244",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.89G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 26,
        "demographics": "Patients with ATTRv V30M, including individuals with early and late onset.",
        "phenotype": "Neuropathy and cardiomyopathy."
      },
      "penetrance_data": {
        "total_carriers_observed": 140,
        "affected_count": 80,
        "unaffected_count": 60,
        "uncertain_count": null,
        "penetrance_percentage": 57.14,
        "age_dependent_penetrance": [
          {
            "age_range": "50 years",
            "penetrance_percentage": 80,
            "carriers_in_range": 100,
            "affected_in_range": 80
          },
          {
            "age_range": "70 years",
            "penetrance_percentage": 91,
            "carriers_in_range": 40,
            "affected_in_range": 36
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": 50,
          "age_at_onset": 45,
          "age_at_diagnosis": 48,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiomyopathy with neuropathy.",
          "evidence_sentence": "A muta\u00e7\u00e3o TTRv V30Met, por exemplo, tem penetr\u00e2ncia em Portugal de 80% aos 50 anos."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": 70,
          "age_at_onset": 65,
          "age_at_diagnosis": 68,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy.",
          "evidence_sentence": "Na Su\u00e9cia, a mesma muta\u00e7\u00e3o tem os valores de 11% e 36%, respectivamente."
        }
      ],
      "functional_data": {
        "summary": "The V30M mutation leads to destabilization of the TTR protein, resulting in amyloid deposition.",
        "assays": [
          "In vitro stability assays",
          "Functional assays assessing amyloid formation"
        ]
      },
      "segregation_data": "Segregates with disease in families with a history of ATTRv.",
      "population_frequency": "Endemic in Portugal, Sweden, and Japan.",
      "evidence_level": "High",
      "source_location": "Main Text, Section 3.3",
      "additional_notes": "The V30M mutation is the most common variant associated with ATTRv.",
      "key_quotes": [
        "A muta\u00e7\u00e3o V30M \u00e9 a mais disseminada pelo mundo.",
        "A penetr\u00e2ncia da muta\u00e7\u00e3o TTRv V30Met \u00e9 vari\u00e1vel dependendo da regi\u00e3o."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.364G>A",
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 3,
        "demographics": "Afro-American patients over 60 years.",
        "phenotype": "Cardiomyopathy."
      },
      "penetrance_data": {
        "total_carriers_observed": 100,
        "affected_count": 34,
        "unaffected_count": 66,
        "uncertain_count": null,
        "penetrance_percentage": 34,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_3",
          "age_at_evaluation": 62,
          "age_at_onset": 60,
          "age_at_diagnosis": 61,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiomyopathy with heart failure.",
          "evidence_sentence": "Outra muta\u00e7\u00e3o bastante frequente \u00e9 a V122I, que est\u00e1 presente em 3,4% dos afro-americanos."
        }
      ],
      "functional_data": {
        "summary": "The V122I mutation is associated with increased amyloidogenicity of TTR.",
        "assays": [
          "Stability assays",
          "Amyloid fibril formation assays"
        ]
      },
      "segregation_data": "Segregates with disease in families with a history of cardiomyopathy.",
      "population_frequency": "3.4% in Afro-American population.",
      "evidence_level": "High",
      "source_location": "Main Text, Section 3.3",
      "additional_notes": "The V122I mutation is particularly associated with late-onset cardiomyopathy.",
      "key_quotes": [
        "A muta\u00e7\u00e3o V122I est\u00e1 presente em 3,4% dos afro-americanos.",
        "A progress\u00e3o da neuropatia leva \u00e0 incapacidade sensitivo-motora."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data extracted from the main text."
  }
}